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Fred Dyda* and Alison B HickmanAbstract
It has recently become clear that many bacterial and archaeal species possess adaptive immune systems. These are
typified by multiple copies of DNA sequences known as clustered regularly interspaced short palindromic repeats
(CRISPRs). These CRISPR repeats are the sites at which short spacers containing sequences of previously encountered
foreign DNA are integrated, and the spacers serve as the molecular memory of previous invaders. In vivo work has
demonstrated that two CRISPR-associated proteins - Cas1 and Cas2 - are required for spacer integration, but the
mechanism by which this is accomplished remained unclear. Here we review a recent paper describing the
in vitro reconstitution of CRISPR spacer integration using purified Cas1 and Cas2 and place the results in context
of similar DNA transposition reactions and the crystal structure of the Cas1/Cas2 complex.
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The clustered regularly interspaced short palindromic
repeats (CRISPR)/CRISPR-associated (Cas) system, present
in approximately 90% of archaea and approximately 50% of
bacteria, is an adaptive immune system (reviewed in [1])
that generates small RNAs (known as crRNAs) transcribed
from chromosomally integrated foreign DNA fragments
and uses them to direct the degradation of invading DNA
that contains the same sequence. The foreign DNA frag-
ments, called ‘spacers’, are integrated into a chromosomal
CRISPR locus composed of an array of short palindromic
repeats forming a repeat-spacer-repeat pattern (Figure 1A).
Adjacent to the CRISPR locus is the several hundred base
pairs long AT-rich ‘leader sequence’ preceded by the cas
genes. The cas genes associated with CRISPR systems are
quite variable, with over 45 different gene families identi-
fied in various organisms. Although six cas genes (cas1
to 6) are extensively conserved, only cas1 and cas2 are
always present in those genomes that contain a CRISPR
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unless otherwise stated.The phenomenon of CRISPR/Cas immunity can be
divided into three processes: adaptation, crRNA biogen-
esis, and crRNA-based interference. In adaptation, a
30- to 40-bp fragment of foreign DNA is integrated
orientation-specifically at the DNA palindrome next to
the leader sequence in a process that duplicates the pal-
indrome such that the spacer is flanked by two of them
after integration (Figure 1B). Pre-crRNA is produced as
a long transcript from the promoter in the leader and
subsequently matured into short crRNAs. The exact
process of crRNA biogenesis differs significantly in the
three different major types of CRISPR/Cas systems. Target
destruction is also mediated by very different protein
players in the three major CRISPR/Cas types. Large and
complex nucleoprotein assemblies are involved that
organize base pairing between crRNA with one strand
of a partially melted complementary foreign DNA. It is
the type II systems that use Cas9 for targeting and de-
struction that are currently the best understood.
Although Cas1 and Cas2 are necessary and sufficient
for the insertion of a protospacer in CRISPR loci in vivo
[2], the details of the mechanism have remained unclear.
A recent report by Nuñez et al. [3] describes the in vitro
reconstitution of protospacer insertion, shedding light
onto many aspects of adaptation.entral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Overview and details of a CRISPR locus. (A) Clustered regularly
interspaced short palindromic repeats (CRISPRs, in green) typically
alternate with spacers of different sequence but similar length
(shades of gray and black). (B) Proposed double-ended integration
of a protospacer (red) into the site of a CRISPR repeat. This results
in a duplication of the CRISPR. (C) Sequence and deduced cruciform
structure of the E. coli 28 nt CRISPR repeat.
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The recent in vitro reconstitution of the crucial spacer
integration step using purified Cas1 and Cas2 proteins,
synthetic oligonucleotides, and plasmid substrates repre-
sents a major step forward in defining the fundamental
biochemistry of the process [3]. In the presence of divalent
metal ions (Mg2+ or Mn2+), Cas1 and Cas2 were sufficient
to integrate 33-bp protospacers into supercoiled CRISPR-
containing plasmid substrates. Although Cas2 was not ab-
solutely required, it greatly enhanced the reaction. The
terminal 3′-OH of the protospacer was critical, and the
products obtained were very similar to those seen during
in vitro DNA transposition and retroviral integration reac-
tions. Furthermore, the data were consistent with inte-
gration occurring via a direct nucleophilic attack by the
protospacer terminal 3′-OH on the target scissile phos-
phate without the involvement of tyrosine or serine
residues located in the Cas1 active site. It was also
demonstrated that, similarly to retroviral integrases [4],
Cas1 could catalyze a disintegration reaction in which
it was able to release a protospacer that had been inte-
grated at one of its ends from a target DNA molecule.Cas2 did not enhance disintegration but it did not in-
hibit it either.
One surprising finding was the appearance of an unex-
pected product, not observed in known DNA transpos-
ition and retroviral integration reactions, that the authors
termed ‘Band X’. This turned out to be several products
most closely resembling topoisomers of the target super-
coiled plasmid. Significantly, none of these products con-
tained integrated protospacers. The authors suggested as a
possible explanation that products are the result of one-
ended protospacer integration followed by disintegration
that reseals the target plasmid in a series of partially re-
laxed topoisomers, indicative of reversability. While this is
reasonable, the observed products were also consistent
with simple nicking and resealing of the target plasmid by
Cas1 and Cas2. While Cas1 alone can catalyze disintegra-
tion, the formation of Band X seemed to require both
Cas1 and Cas2.
Most DNA transposition systems generate target site
duplications (TSDs) of a characteristic length that is a
property of the particular system. TSDs arise as the two
3′-OH groups at the transposon ends (one on the top
strand and one on the bottom) are joined to target DNA
with a few base pair stagger during double-ended inte-
gration. The precise number of base pairs is dependent
on the distance between the active sites of transposase
molecules in the multimeric transpososome that always
contains at least a dimer of the transposase. Similarly,
CRISPR spacer acquisition in vivo results in duplication
of the CRISPR repeat in the target, again suggesting
double-ended integration (where the ends correspond to
the two ends of a single protospacer). In the Escherichia
coli system studied, this is equivalent to generating 28 bp
TSDs, which is rather long when compared to TSDs
commonly observed with DNA transposons. However,
the physical distance between the points of the attacks
could be much shorter than implied by 28 bp of B-form
dsDNA (which would be approximately 90 Å) because
of the likely hairpin structure of the CRISPR repeat
(Figure 1C).
While the reported in vitro system seems efficient in
generating single-ended integrations, it is much less so
in generating double-ended ones. Generating efficient
double-ended integrations in an in vitro reconstituted
system is not always easy, as has been seen in the early
work on retroviral integrases, for instance [5]. Further-
more, in vitro, the presence of the CRISPR locus in the
supercoiled target plasmid is not absolutely necessary to
observe integration events. Nevertheless, if the CRISPR
locus is cloned into a pUC19 backbone, it is the preferred
site of integration, attracting 71% of all integrations. A fur-
ther indication that the in vitro system recapitulates the
fundamental properties of the system is that integrations
that did go into the CRISPR locus showed a preference for
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tion bias, as 73% of the integrations into the CRISPR locus
showed integration of the 3′ terminal C of the protospacer
into the target (−) strand, and not the 3′ T of the opposite
strand (Figure 1B). This is significant since the presence of
corresponding 5′ G of the spacer is important to establishFigure 2 Structure of the Cas1/Cas2 complex (PDB code 4P6I). Cas1 protom
dimer in blue and green. (A) Arrows show the active sites (marked by His2
to the Cas2 dimer. The distance between the active sites, which point awa
view of the complex assembly reveals that the active sites of the other two
towards each other (as expected if these active sites mediate coordinated
However, the as-the-crow-flies connection between these two active sitesthe AAG protospacer-adjacent motif (PAM), which is
critical for crRNA interference to work in E. coli.
Taken together, the features of the reconstituted in vitro
system established in [3] are consistent with in vivo data
and display strong similarities to DNA transposition.
However, the protein architectures of neither Cas1 norers (labelled as in [7]) are shown in gold and orange, the central Cas2
08, shown as blue sticks) of the two Cas1 protomers that bind directly
y from each other, is approximately 81 Å. (B) Horizontal rotation of the
Cas1 protomers in the heterohexamer are more convincingly pointed
integration of a protospacer) and are separated by approximately 93 Å.
passes directly through the intervening Cas2 dimer.
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transposases that use direct nucleophilic attack, as they
are not members of the retroviral integrase superfamily
and do not use three carboxylate side chains (the so-
called DDE/D motif) as active site residues. Rather, Cas1
has a unique fold and an active site residue constellation
of conserved E, N, H, and D/E residues [6] (Figure 2A).
The E/H/D triad has been observed to coordinate a diva-
lent metal ion [6], and mutation of the D abolished the
nonspecific nuclease activity of Cas1 [6]. Reassuringly,
mutations of the metal-coordinating H and D residues
in Cas1 abolished protospacer integration in vitro, im-
plicating the involvement of Cas1’s active site.
The role of Cas2 is less clear. It has been reported to
be an endonuclease that can act on a variety of substrates
[6,7]; however, mutations of active site residues that are
important for these activities do not appear to have an ef-
fect on spacer acquisition either in vivo or in vitro [3,7].
Cas1 and Cas2 have been shown to bind to each other,
and mutations in the interface that prevent protein-
protein interaction were defective in spacer acquisition
in vivo [7]. Adding to the complexity is that Cas2 is an
obligatory dimer, so it is possible that the relevant as-
sembly is a heterotetramer with the Cas2 dimer in the
middle with two Cas1 protomers bound on either side
(Figure 2B). However, in the crystal structure of the
Cas1/Cas2 complex [7], there are two additional Cas1
monomers attached to the heterotetramer through a
Cas1/Cas1 interface, making a heterohexameric assembly
(Figure 2B). While this assembly is not supported by solu-
tion data, the Cas1/Cas1 dimer is twofold symmetric, as
usually observed for biologically relevant dimers.
By analogy to DNA transposition reactions, double-ended
integration of the protospacer would presumably re-
quire two Cas1 active sites. In the crystal structure of
the Cas1/Cas2 complex, the distance between the active
sites of the Cas1 protomers bound directly to the Cas2
dimer is 81 Å. This is long, but if there is some unfold-
ing of the CRISPR hairpin, it is not unreasonable. In
such a model, the CRISPR repeat could be bound by the
central Cas2 dimer (Figure 2), where it would possess a
dual role as a target binder and dimerization scaffold, nei-
ther of which would require endonuclease activity. The
difficulty with this view is that these two Cas1 active sites
point away from each other so it is very difficult to see
how the two 3′-OH groups of an approximately 30-bp
protospacer could be simultaneously bound to these active
sites. On the other hand, one could also envisage a path
that DNA could take between the active sites of the two
‘outer’ Cas1 protomers in the heterohexamers (assuming
these exist in vivo and not only in crystal structures) as
these active sites at least do not point away from each
other. Still, with the approximately 93-Å distance between
these, it becomes more difficult to imagine how these twocould carry out a double-ended integration event of ap-
proximately 30-bp-long protospacers.
Conclusions
The currently available data strongly indicate that CRISPR
spacer acquisition is a form of DNA mobility with intri-
guing similarities to transposition yet employing protein ar-
chitectures and complex assemblies distinct from what has
been seen before in transposition. There is yet another link
between CRISPR systems and transposition: recently, a
family of Cas1 proteins not associated with CRISPR loci
was discovered whose members are encoded by the hypo-
thetical mobile elements designated as casposons [8]. This
led to the proposal that parts of the CRISPR system may
have their evolutionarily origin in a mobile genetic element
[8,9], much like the RAG1 recombinase (involved in the
adaptive immune system of vertebrates) originated from
the transposase of a eukaryotic Transib transposon [10].
The notion is provocative that a Cas1 protein might act as
a transposase [11], perhaps alone or in complex with some
other currently unidentified partner or partners.
As currently no structural information is available
about how the Cas1/Cas2 complex interacts with DNA,
there is a lot that has to be left to the imagination. It is
unclear how orientation specificity and leader recognition
is accomplished, as these imply some breakdown of the
twofold symmetry of the Cas1/Cas2 complex. Perhaps one
thing is almost certain: a number of big surprises are wait-
ing as was the case when the first DNA transpososome
structures became available [12].
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